Aryl propanolamines: Comparison of activity at human β3 receptors, rat β3 receptors and rat atrial receptors mediating tachycardia

British Journal of Pharmacology

Volumn 126, Issue 4, 1999, Pages 1018-1024

  Cohen, Marlene L ^a   Bloomquist, William ^a   Kriauciunas, Aidas ^a   Shuker, Anthony ^a   Calligaro, David ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

'Atypical' receptor; Human 3 receptor; Propanolamines; Rat atria tachycardia; Rat stomach fundus

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; HEART RECEPTOR; N [4 [2 [[2 HYDROXY 3 (4 HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]BENZENESULFONAMIDE; PROPANOLAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART RATE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STOMACH FUNDUS; TACHYCARDIA;

EID: 0032956051     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702364     Document Type: Article

References (16)

1. BLUE, D.R., BOND, R.A., ADHAM, N., DELMONDO, R., MICHEL, A.D., EGLEN, R.M., WHITING, R.L. & CLARK, D.E. (1989). Interaction of dihydroalprenolol and cyanopindolol with atypical β-adrenergic receptors in guinea-pig ileum. Br. J. PharmacoL, 96, 246.
2. BYLUND, D.B. & SNYDER, S.H. (1976). Beta adrenergic receptor binding in membrane preparation from mammalian brain. Mol. PharmacoL, 12, 568-580.
3. 50) of an enzymatic reaction. Biochem. PharmacoL. 22, 3099-3108.
4. 3 receptor? J. PharmacoL Exp. Ther., 272, 446-451.
5. COHEN, M.L., SARAZAN, R.D., KLOTZ, U., BLOOMQUIST, W. & PALKOWITZ, A. (1995b). Effect of beta-3 selective agonists, BRL 37,344 and CL 316,243 on blood pressure and heart rate in the rat. J. Drug. Dev. Clin. Pract., 7, 37-44.
6. COHEN, M.L., WILEY, K.S. & BEMIS, K.G. (1982). Analysis of the Beta 1 and Beta2 adrenoceptor interactions of the partial agonist, clenbuterol (NAB365), in the rat jugular vein and atria. NaunynSchmied Arch. Pharmacol.,320, 145-151.
7. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J.Physiol.,235,E9T-E102.
8. DOW, R.L. (1997). Beta3-adrenergic agonists: potential therapeutics for obesity. Expert Opinion on Invesligalional Drugs (UK), 6, 1811-1825.
9. GRANNEMAN, J.G., LAHNERS, K.N. & CHAUNDRY, A. (1993). Characterization of the human beta 3-adrenergic receptor gene. Molecular Pharmacology, 44, 264 -270.
10. GRINNELL, B.W., BERG, D.T., WALLS, J. &. YAN, S.B. (1987). Transactivated expression of fully gamma-carboxylated recombinant human protein C, an antithrombotic factor. Bio/Technology, 5, 1189-1192.
11. KAUMANN, A.J. (l 996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol, 117,93-98.
12. 3-adrenoceptor in the rat. Br. J. Pharmacol.. 118, 2085-2098.
13. 3-adrenoceptors. Br. J. Pharmacol., 117, 943-949.
14. 3 adrenoceptor) mediating relaxation in the rat distal colon in vitro. Br. J. Pharmacol., 101, 569-574.
15. MUNSON, P.J. & RODBARD, D. (1980). Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
16. SECREST, R.J., LUCAITES, V.L., MENDELSOHN, L.G. & COHEN, M.L. (1991). Protein kinase C translocation in rat stomach fundus: Effects of serotonin carbamylcholine, and phorbol dibutyrate. J. Pharmacol. Exp. Tlier., 256, 103-109.